Edition:
United Kingdom

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

7.85USD
7:29pm GMT
Change (% chg)

$-0.14 (-1.81%)
Prev Close
$7.99
Open
$8.00
Day's High
$8.10
Day's Low
$7.84
Volume
12,261
Avg. Vol
49,922
52-wk High
$14.90
52-wk Low
$6.70

Chart for

About

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads... (more)

Overall

Beta: -0.59
Market Cap(Mil.): $173.02
Shares Outstanding(Mil.): 28.13
Dividend: --
Yield (%): --

Financials

  CTSO.OQ Industry Sector
P/E (TTM): -- 192.18 32.54
EPS (TTM): -0.37 -- --
ROI: -77.87 9.61 13.82
ROE: -162.40 15.50 15.25

Earnings vs. Estimates